
Carolina Reduzzi/LinkedIn
Aug 14, 2025, 05:42
Carolina Reduzzi: Exploring MRD Detection in Solid Tumors With Natera Test with Samuel Vilchez
Carolina Reduzzi, Assistant Professor of Cancer Biology Research in Medicine and Director of Cristofanilli CTC laboratory at Weill Cornell Medicine, shared a post on LinkedIn:
“The Liquid Biopsy Series of Weill Cornell Medicine and EIPM will be back Friday Aug 22nd at 12:30-1:30pm ET! Samuel Vilchez will talk about MRD assessment in patients with solid tumors using the Natera test.
Join on zoom here.”
More posts featuring Carolina Reduzzi.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 14, 2025, 05:27
Aug 14, 2025, 03:06
Aug 14, 2025, 03:04
Aug 13, 2025, 21:09